Document is current
Any future updates will be listed below
-
Authors
Charitakis, Natalie
Salim, Agus
Piers, Adam T.
Watt, Kevin I.
Porrello, Enzo R.
Elliott, David A.
Ramialison, Mirana https://orcid.org/0000-0001-6315-4777
-
Funding
Funding for this research was provided by:
National Health and Medical Research Council of Australia
Stafford Fox Medical Research Foundation
Royal Children's Hospital Foundation
Novo Nordisk Foundation Center for Stem Cell Medicine (NNF21CC0073729)
Victorian Government’s Operational Infrastructure Support Program
Royal Children’s Hospital Foundation
Novo Nordisk Foundation Center for Stem Cell Medicine (NNF21CC0073729, NNF21CC0073729)
- License Information
-
More Information
Article History
Received: 21 October 2022
Accepted: 21 August 2023
First Online: 18 September 2023
Declarations
:
: NA.
: NA.
: ERP is a cofounder, scientific advisors, and holds equity in Dynomics, a biotechnology company focused on the development of heart failure therapeutics. The other authors report no conflicts.
